DelMar Pharmaceuticals, Inc. 4
4 · DelMar Pharmaceuticals, Inc. · Filed Mar 20, 2014
Insider Transaction Report
Form 4
Garner William J
Director
Transactions
- Sale
Common Stock
2014-03-18$1.30/sh−25,000$32,500→ 65,000 total - Sale
Common Stock
2014-03-18$1.30/sh−10,000$13,000→ 20,000 total - Sale
Common Stock
2014-03-18$1.30/sh−25,000$32,500→ 40,000 total - Sale
Common Stock
2014-03-18$1.30/sh−10,000$13,000→ 10,000 total - Sale
Common Stock
2014-03-18$1.30/sh−10,000$13,000→ 30,000 total - Conversion
Exchangeable Shares
2014-03-18$0.01/sh−80,000$400→ 2,513,541 total(indirect: See footnote)→ Common Stock (80,000 underlying) - Conversion
Common Stock
2014-03-18+80,000→ 90,000 total
Footnotes (3)
- [F1]Exchangeable Shares are shares of Exchangeco (as such terms are defined in the Issuer's Current Report on Form 8-K filed with the SEC on January 31, 2013) which are exchangeable on a 1-for-1 basis at any time for shares of common stock in the Issuer.
- [F2]Shares are held in trust by Jeffrey Bacha.
- [F3]5,000 shares are held by EGB Advisors, LLC, which is owned by Mr. Garner, and the remainder are held directly by Mr. Garner.